Patent details

90160 Product Name: Naratriptan, facultativement sous la forme d'un sel pharmaceutiquement acceptable ou d'un solvate, y compris le chlorhydrate de naratriptan.

Basic Information

Publication number:
90160
Type:
SPC
SPC Type:
Medical
Basic Patent Number:
EP883074999
Legal Status:
Expired
Application number:
90160
First applicant's nationality:
Procedural language:
French

Marketing Authorization

1

Marketing Authorization Number:
0260/97/09/0253
Marketing Authorization Type:
Marketing Authorization Date:
17/09/1997
Marketing Authorization Status:
Accepted
Marketing Authorization Country:
Luxembourg (LU)

2

Marketing Authorization Number:
13382
Marketing Authorization Type:
Marketing Authorization Date:
10/03/1997
Marketing Authorization Status:
Accepted
Marketing Authorization Country:

Dates

Filing date:
31/10/1997
First Marketing Authorization date:
10/03/1997
Grant date:
14/01/1998
Activation date:
12/08/2008
Publication date:
14/01/1998
Lapsed date:
Expiration date:
Renunciation date:
Revocation date:
Annulment date:
Basic SPC Expiration:
10/03/2012
SPC Extension Expiration:
10/03/2012
Rejection date:
Withdrawal date:

Owner

From:
31/10/1997
 
 

Name:
GLAXO GROUP LIMITED
Address:
GLAXO WELLCOME HOUSE, BERKELEY AVENUE, GREENFORD, MIDDLESEX UB6 0NN, United Kingdom (GB)

Agent

Name:
WEYLAND J.J. PIERRE, DR
From:
31/10/1997
Address:
PO Box 1775, 1017, Luxembourg, Luxembourg (LU)
To:
Filing date Document type Number of pages